Andexxa - NDC Database
3 records found
Page:
0310-3200 Jul 12, 2022
Andexxa 200 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Astrazeneca Pharmaceuticals Lp
Andexxa 200 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Astrazeneca Pharmaceuticals Lp
69853-0101 May 14, 2018
Andexxa 100 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Portola Pharmaceuticals
Andexxa 100 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Portola Pharmaceuticals
69853-0102 Jan 08, 2019
Andexxa 200 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Portola Pharmaceuticals
Andexxa 200 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Portola Pharmaceuticals
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.